Leadiant Biosciences, Inc. announced that Health Canada has approved Cysklar® (cysteamine ophthalmic solution) 0.44%, a ...
Pharmaceutical Technology on MSN
Health Canada approves Biocon’s two denosumab biosimilars
Denosumab therapies are used to increase bone mass and treat osteoporosis, as well as address bone complications in cancer.
Health Canada has approved the first needle-free epinephrine treatment for severe allergic reactions: a nasal spray called ...
Ongoing price erosion in key products remains a lingering concern for Dr. Reddy's and therefore, Goldman Sachs has cut its ...
With the authorization of PrUpgolyv™ (golimumab injection) by Health Canada, JAMP Pharma Group continues to build momentum in its immunology-focused biosimilars pipeline, delivering innovative, ...
Biocon receives Health Canada's compliance notice for biosimilars Bosaya and Vevzuo, enhancing treatment options for ...
Ottawa's cuts to health-care funding over the next three years will negatively affect ambulance services in Prince Edward ...
Health Canada is warning Canadians against injecting unauthorized peptides bought online, citing possible risks of organ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results